story of the week
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
N. Engl. J. Med 2024 Dec 09;[EPub Ahead of Print], MA Dimopoulos, PM Voorhees, F Schjesvold, YC Cohen, V Hungria, I Sandhu, J Lindsay, RI Baker, K Suzuki, H Kosugi, MD Levin, M Beksac, K Stockerl-Goldstein, A Oriol, G Mikala, G Garate, K Theunissen, I Spicka, AK Mylin, S Bringhen, K Uttervall, B Pula, E Medvedova, AJ Cowan, P Moreau, MV Mateos, H Goldschmidt, T Ahmadi, L Sha, A Cortoos, EG Katz, E Rousseau, L Li, RM Dennis, R Carson, SV RajkumarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.